leisure time -WSS

leisure time

author：comprehensive 2025-09-27 12:21:41 - browse：8576

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： World's first CRISPR

explore

WSS

Weight loss drug costs may need more research, senator suggests

Ransomware attacks on hospitals: Study outlines patient impact

Surgery pushed Ben Carson to fame

Global cancer cases to surge 77% by 2050, WHO report says

Texas Medical Board asked to define abortion emergency exception

Childhood cancer progress stalls for Black, Hispanic kids: Report

hotspot

leisure time

knowledge

Wildfire smoke exposes gaps in outdoor worker protections

Weight loss drug costs may need more research, senator suggests

In age of alternative facts, a scholarly course on calling out crap

Gene therapy for Afghan refugees’ infant will be fully covered

Moonlake's readout produced a cash windfall. Risks remain

PBM reforms clear House panel

The cancer drug shortage isn’t new — and neither are the solutions

Unique patient identifier: Experts argue the benefits, pitfalls

Apple is now the first public company to be valued at $3 trillion

Gain of function research would be limited under House proposal

hotspot

Readout Newsletter: Amgen, Regeneron, BGI Group and more

What’s missing from the debate over nursing home staff minimums

Astellas still sees hope in its gene therapy after four deaths

AstraZeneca stays mum on Medicare drug pricing negotiations

Weight loss drug costs may need more research, senator suggests

Weight loss drug costs may need more research, senator suggests

explore

hotspot

leisure time

knowledge